Profund Advisors’s Cantel Medical Corporation CMD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q2 | – | Sell |
-3,185
| Closed | -$254K | – | 1445 |
|
|
2021
Q1 | $254K | Buy |
3,185
+306
| +11% | +$23.9K | 0.01% | 1112 |
|
|
2020
Q4 | $227K | Buy |
+2,879
| New | +$169K | 0.01% | 1024 |
|
|
2020
Q1 | – | Sell |
-2,994
| Closed | -$212K | – | 1230 |
|
|
2019
Q4 | $212K | Sell |
2,994
-37
| -1% | -$2.68K | 0.01% | 1143 |
|
|
2019
Q3 | $227K | Sell |
3,031
-452
| -13% | -$38.3K | 0.01% | 1114 |
|
|
2019
Q2 | $281K | Sell |
3,483
-589
| -14% | -$41.4K | 0.01% | 957 |
|
|
2019
Q1 | $272K | Buy |
4,072
+935
| +30% | +$70.8K | 0.01% | 974 |
|
|
2018
Q4 | $234K | Sell |
3,137
-2,010
| -39% | -$166K | 0.01% | 941 |
|
|
2018
Q3 | $474K | Buy |
5,147
+637
| +14% | +$60.7K | 0.02% | 867 |
|
|
2018
Q2 | $444K | Sell |
4,510
-1,199
| -21% | -$134K | 0.02% | 871 |
|
|
2018
Q1 | $636K | Buy |
5,709
+606
| +12% | +$67.9K | 0.03% | 649 |
|
|
2017
Q4 | $525K | Buy |
5,103
+761
| +18% | +$75.8K | 0.02% | 786 |
|
|
2017
Q3 | $409K | Sell |
4,342
-2,632
| -38% | -$208K | 0.02% | 886 |
|
|
2017
Q2 | $543K | Buy |
6,974
+666
| +11% | +$50K | 0.02% | 686 |
|
|
2017
Q1 | $505K | Sell |
6,308
-137
| -2% | -$10.9K | 0.02% | 835 |
|
|
2016
Q4 | $508K | Buy |
6,445
+877
| +16% | +$68.1K | 0.02% | 888 |
|
|
2016
Q3 | $434K | Buy |
5,568
+870
| +19% | +$63.1K | 0.02% | 855 |
|
|
2016
Q2 | $323K | Sell |
4,698
-258
| -5% | -$17.8K | 0.02% | 1075 |
|
|
2016
Q1 | $354K | Sell |
4,956
-1,756
| -26% | -$110K | 0.02% | 977 |
|
|
2015
Q4 | $417K | Buy |
6,712
+1,502
| +29% | +$91.6K | 0.02% | 748 |
|
|
2015
Q3 | $295K | Sell |
5,210
-2,940
| -36% | -$156K | 0.02% | 847 |
|
|
2015
Q2 | $437K | Sell |
8,150
-3,610
| -31% | -$176K | 0.02% | 861 |
|
|
2015
Q1 | $559K | Buy |
11,760
+5,034
| +75% | +$223K | 0.02% | 826 |
|
|
2014
Q4 | $291K | Buy |
+6,726
| New | +$275K | 0.01% | 1147 |
|
|
2014
Q3 | – | Sell |
-8,462
| Closed | -$310K | – | 1480 |
|
|
2014
Q2 | $310K | Buy |
8,462
+441
| +5% | +$15K | 0.01% | 1189 |
|
|
2014
Q1 | $270K | Sell |
8,021
-3,020
| -27% | -$99.6K | 0.01% | 1272 |
|
|
2013
Q4 | $374K | Buy |
11,041
+2,867
| +35% | +$99.3K | 0.02% | 1239 |
|
|
2013
Q3 | $260K | Buy |
+8,174
| New | +$217K | 0.01% | 1383 |
|
Profund Advisors's CMD Position: Q2 2021 in Review
Profund Advisors sold out of Cantel Medical Corporation (CMD) in Q2 2021, closing a stake of 3,185 shares — an estimated $254K sold.
Profund Advisors first reported a position in CMD in Q3 2013 and held it in 27 quarters. The position peaked at $636K in Q1 2018. 0 funds tracked by Wall St. Rank hold CMD as of Q2 2021.
- Profund Advisors reported no remaining Cantel Medical Corporation position as of Q2 2021 after selling out during the quarter.
- Profund Advisors sold 3,185 Cantel Medical Corporation shares in Q2 2021, an estimated $254K.
- Profund Advisors first reported a position in Cantel Medical Corporation in Q3 2013 and held it in 27 quarters.
- Profund Advisors's Cantel Medical Corporation position peaked at $636K in Q1 2018.
- 0 funds tracked by Wall St. Rank held Cantel Medical Corporation as of Q2 2021.
Based on Profund Advisors's 13F filing for Q2 2021, filed 12 Aug 2021.